The market is up 2.7% over the last week and has seen a 21% increase over the past year, with earnings forecasted to grow by 17% annually. In such a thriving market, identifying stocks that blend value and growth potential can be particularly rewarding. Penny stocks, though an older term, still represent smaller or newer companies that might offer unique opportunities when backed by strong financials. We will explore three penny stocks that stand out for their balance sheet resilience and potential for long-term success.

Let's explore several standout options from the results in the screener.

Myriad Genetics (MYGN)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company that develops molecular tests, with a market cap of approximately $311.82 million.

Operations: The company generates revenue primarily from its Biotechnology segment, which amounts to $806.6 million.

Market Cap: $311.82M

Myriad Genetics, with a market cap of US$311.82 million, reported second-quarter sales of US$190.7 million but continues to operate at a loss, reporting a net loss of US$43.2 million for the quarter. The company recently lowered its full-year revenue guidance to between US$770-790 million due to declining prenatal health test volumes and cautious revenue assumptions per test. Despite these challenges, Myriad's strategic partnership with Burning Rock Biotech aims to expand HRD testing solutions globally, potentially enhancing its market reach and product offerings in precision medicine diagnostics across various cancer types.

Claros Mortgage Trust (CMTG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Claros Mortgage Trust, Inc. operates as a real estate investment trust with a market cap of approximately $273.70 million.

Operations: The company's revenue is primarily derived from its REO Portfolio, which generated $78.17 million, and its Loan Portfolio, contributing $37.32 million.

Market Cap: $273.7M

Claros Mortgage Trust, with a market cap of US$273.70 million, is currently unprofitable and reported a net loss of US$255.43 million for Q2 2026, an increase from the previous year. Despite its financial struggles, the company maintains a strong cash runway exceeding three years under stable conditions and was recently added to multiple Russell indices, potentially increasing its visibility among investors. However, its high debt-to-equity ratio of 200% raises concerns about financial leverage. Recent management changes include the appointment of D. Pike Aloian to the board following Andrew Silberstein's resignation due to retirement.

Nextdoor Holdings (NXDR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nextdoor Holdings, Inc. operates a neighborhood network connecting neighbors, businesses, and public agencies both in the United States and internationally, with a market cap of approximately $986.46 million.

Operations: The company's revenue is primarily generated from its Internet Information Providers segment, which amounts to $274.6 million.

Market Cap: $986.46M

Nextdoor Holdings, with a market cap of US$986.46 million, reported Q2 2026 sales of US$74.55 million, up from the previous year, while reducing its net loss significantly to US$2.12 million. The company is debt-free and has a robust cash runway exceeding three years due to positive free cash flow growth of 29.7% annually despite being unprofitable. Its short-term assets substantially cover liabilities, but management's relatively short tenure suggests inexperience. Recent integration with Freshpaint aims to enhance healthcare advertising effectiveness by linking neighborhood-level campaigns to patient outcomes without compromising privacy or compliance standards.

Summing It All Up

• Investigate our full lineup of 327 US Penny Stocks right here.
• Curious About Other Options? We've found 9 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.